Resultados de búsqueda - Jörn Bramstedt

  • Mostrando 1 - 5 Resultados de 5
Limitar resultados
  1. 1
    Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

    Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the Ger... por Jan T. Kielstein, Gernot Beutel, Susanne Fleig, Jürgen Steinhoff, Tobias Meyer, Carsten Hafer, Uwe Kuhlmann, Jörn Bramstedt, Ulf Panzer, Martin Vischedyk, Veit Busch, W Ries, Steffen Mitzner, Stefan Mees, Sylvia Stracke, Jens Nürnberger, Peter Gerke, Monika Wiesner, B Sucké, Miriam Abu-Tair, Andreas Kribben, Norbert Klause, Ralf Schindler, Frank Merkel, Sabine Schnatter, Eiske M. Dorresteijn, Ola Samuelsson, R. Brunkhorst

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

    ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP por Linus A. Völker, Jessica Kaufeld, Wolfgang Miesbach, Sebastian Brähler, Martin Reinhardt, Lucas Kühne, Anja Mühlfeld, Adrian Schreiber, Jens Gaedeke, Markus Tölle, Wolfram J. Jabs, Fedai Özcan, Silke Markau, Matthias Girndt, Frederic Bauer, Timm H. Westhoff, H Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Markus Bieringer, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Anja Gäckler, Andreas Kribben, Vedat Schwenger, Ulf Schoenermarck, Maximilian von Roeder, Jörg Radermacher, Jörn Bramstedt, Anke Morgner, Regina Herbst, Ana Harth, Sebastian A. Potthoff, Charis von Auer, Ralph Wendt, Hildegard Christ, Paul T. Brinkkoetter, Jan Menne

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

    Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura por Linus A. Völker, Jessica Kaufeld, Wolfgang Miesbach, Sebastian Brähler, Martin Reinhardt, Lucas Kühne, Anja Mühlfeld, Adrian Schreiber, Jens Gaedeke, Markus Tölle, Wolfram J. Jabs, Fedai Özcan, Silke Markau, Matthias Girndt, Frederic Bauer, Timm H. Westhoff, H Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Markus Bieringer, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Anja Gäckler, Andreas Kribben, Vedat Schwenger, Ulf Schoenermarck, Maximilian von Roeder, Jörg Radermacher, Jörn Bramstedt, Anke Morgner, Regina Herbst, Ana Harth, Sebastian A. Potthoff, Charis von Auer, Ralph Wendt, Hildegard Christ, Paul T. Brinkkoetter, Jan Menne

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

    Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study por Jan Menne, Martin Nitschke, Robert Stingele, M. Abu-Tair, Jan Beneke, Jörn Bramstedt, Jan Phillip Bremer, R. Brunkhorst, Veit Busch, Reinhard Dengler, Günther Deuschl, Klaus Fellermann, Helmut Fickenscher, C. Gerigk, A. Goettsche, J. Greeve, Carsten Hafer, F. Hagenmüller, Herman Haller, Stefan Herget‐Rosenthal, Bernd Hertenstein, C. Hofmann, Melanie Lang, Jan T. Kielstein, Ulrich C. Klostermeier, Johannes K.‐M. Knobloch, M. Kuehbacher, Ulrich Kunzendorf, Hendrik Lehnert, Michael P. Manns, Tobias Menne, Thomas Meyer, C. Michael, TF Münte, Christine Neumann-Grutzeck, J. Nuernberger, Hermann Pavenstaedt, L. Ramazan, Lutz Renders, Jonas Repenthin, W Ries, Axel Rohr, Lars Christian Rump, Ola Samuelsson, Friedhelm Sayk, Bernhard M.W. Schmidt, S. Schnatter, Harald O. Schöcklmann, Stefan Schreiber, Cay Uwe von Seydewitz, J. Steinhoff, Sylvia Stracke, Sebastian Suerbaum, Andreas van de Loo, M. Vischedyk, Karin Weißenborn, Peter Wellhöner, M. Wiesner, Sebastian Zeißig, Jürgen Büning, Mario Schiffer, Tanja Kuehbacher

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura

    Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura por Linus A. Völker, Jessica Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis A. Eichenauer, Thomas Osterholt, Holger Hägele, Martin Kann, Franziska Grundmann, Benedikt Kolbrink, Kevin L. Schulte, Anja Gäckler, Andreas Kribben, Kristina Boss, Sebastian A. Potthoff, Lars Christian Rump, Tilman Schmidt, Anja Mühlfeld, Karsten Schulmann, Matthias Hermann, Jens Gaedeke, Kristin Sauerland, Jörn Bramstedt, Ulrich P. Hinkel, Wolfgang Miesbach, Frederic Bauer, Timm H. Westhoff, Heike Bruck, Veronika Buxhofer‐Ausch, Tobias Müller, Ralph Wendt, Ana Harth, Adrian Schreiber, Evelyn Seelow, Markus Tölle, Christopher Gohlisch, Markus Bieringer, Gesa Geuther, Wolfram J. Jabs, Michael Fischereder, Anke von Bergwelt‐Baildon, Ulf Schönermarck, Paul Knoebl, Jan Menne, Paul T. Brinkkoetter, Fedai Özcan, Silke Markau, Matthias Girndt, H Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Vedat Schwenger, Maximilian von Roeder, Jörg Radermacher, Anke Morgner, Regina Herbst, Charis von Auer

    Publicado 2023
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: